Literature DB >> 10769288

Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy.

P A MacCarthy1, A M Shah.   

Abstract

BACKGROUND: Endothelium-derived nitric oxide (NO) selectively enhances myocardial relaxation and may benefit diastolic function. Left ventricular hypertrophy (LVH) is characterized by abnormal myocardial relaxation and endothelial dysfunction. We investigated endothelium-dependent regulation of LV relaxation in moderate pressure-overload LVH induced by aortic banding in guinea pigs. METHODS AND
RESULTS: Isolated ejecting hearts of banded or sham-operated animals (shams) were studied. The specific agonists for endothelial release of NO, bradykinin (10 nmol/L), and substance P (100 nmol/L) both induced earlier onset of LV relaxation in shams (time to LV dP/dt(min) [tdP/dt(min)], -13.4+/-3.0 and -10.4+/-2.5 ms, respectively) without altering peak LV pressure or LV dP/dt(max). Neither agent altered tdP/dt(min) in banded animals. The ACE inhibitor captopril (1 micromol/L) also selectively reduced tdP/dt(min) in shams via a bradykinin/NO-dependent mechanism but had no effect in banded animals. An exogenous NO donor, sodium nitroprusside (0.1 micromol/L), selectively reduced tdP/dt(min) to a similar extent in both shams and banded animals. Endothelial-type NO synthase (eNOS) protein expression in whole LV homogenate was unaltered in banded animals.
CONCLUSIONS: Endothelium-dependent enhancement of LV relaxation is impaired in moderate pressure-overload LVH, despite a preserved response to exogenous NO. This is not accounted for by altered eNOS expression. These abnormalities may contribute to diastolic dysfunction in LVH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769288     DOI: 10.1161/01.cir.101.15.1854

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  The latest generation of beta-blockers: new pharmacologic properties.

Authors:  Michala E Pedersen; John R Cockcroft
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 2.  The role of nitric oxide in the failing heart.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.

Authors:  Ying Sun; Oscar A Carretero; Jiang Xu; Nour-Eddine Rhaleb; Fangfei Wang; Chunxia Lin; James J Yang; Patrick J Pagano; Xiao-Ping Yang
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

Review 4.  Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

Review 5.  Myocardial contractile effects of nitric oxide.

Authors:  Walter J Paulus; Jean G F Bronzwaer
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

6.  Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.

Authors:  Rami Khayat; William Abraham; Brian Patt; Vincent Brinkman; Jacob Wannemacher; Kyle Porter; David Jarjoura
Journal:  J Card Fail       Date:  2012-07       Impact factor: 5.712

Review 7.  Sleep-disordered breathing in patients with decompensated heart failure.

Authors:  Martin A Valdivia-Arenas; Michael Powers; Rami N Khayat
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

Review 8.  OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea.

Authors:  Kiran Devulapally; Raymond Pongonis; Rami Khayat
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

Review 9.  Nitric oxide in the pathogenesis of cardiac disease.

Authors:  Leopoldo Raij
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

Review 10.  Nitric oxide and coronary vascular endothelium adaptations in hypertension.

Authors:  Andrew S Levy; Justin C S Chung; Jeffrey T Kroetsch; James W E Rush
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.